A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma. Editorial Article uri icon

Overview

publication date

  • January 30, 2007

Research

keywords

  • Mesothelioma
  • Pleural Neoplasms

Identity

Scopus Document Identifier

  • 33847304106

Digital Object Identifier (DOI)

  • 10.1016/j.ejcts.2007.01.011

PubMed ID

  • 17267238

Additional Document Info

volume

  • 31

issue

  • 3